Tuesday, December 20 2011

MIVAC Development creates a new company, Toleranzia AB, for the spin-out of the tolerance inducing Re-TolerogenTM platform.

The development and verification of the tolerance inducing Re-TolerogenTM platform has now reached a point where further development is best done in a separate company. MIVAC Development has therefore created the new company Toleranzia AB together with the inventor Prof. Nils Lycke and key personnel. The ongoing exclusive research collaboration and commercial licensing agreement with Synthon concerning the application of the Re-TolerogenTM platform towards Multiple Sclerosis will be transferred into the new company, along with all personnel currently working with the project.